Leerink Partnrs Reduces Earnings Estimates for Revvity

Key Points

• Leerink Partners has lowered its FY2025 earnings per share estimate for Revvity to $4.86, down from $4.88, while the consensus estimate remains higher at $4.94.
• Various research firms have adjusted their price targets for Revvity, with Stifel Nicolaus setting a target of $110.00 and maintaining a "hold" rating.
• Revvity announced a quarterly dividend of $0.07 per share, with an ex-dividend date of October 17th, representing an annualized yield of 0.3%.

Revvity Inc. (NYSE:RVTY - Free Report) - Equities researchers at Leerink Partnrs cut their FY2025 earnings per share (EPS) estimates for Revvity in a report issued on Sunday, September 14th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings per share of $4.86 for the year, down from their previous forecast of $4.88. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity's Q2 2026 earnings at $1.28 EPS, Q4 2026 earnings at $1.64 EPS, FY2026 earnings at $5.40 EPS and FY2027 earnings at $6.06 EPS.

Several other research firms have also recently commented on RVTY. Stifel Nicolaus dropped their price objective on Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a research report on Tuesday, July 29th. Evercore ISI dropped their target price on Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Bank of America dropped their target price on Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. Raymond James Financial reissued an "outperform" rating and issued a $115.00 target price (down from $120.00) on shares of Revvity in a research report on Tuesday, July 29th. Finally, Wall Street Zen cut Revvity from a "buy" rating to a "hold" rating in a research report on Sunday, August 3rd. Ten investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, Revvity has an average rating of "Moderate Buy" and a consensus price target of $120.07.

Revvity Trading Up 1.4%

Revvity stock opened at $84.06 on Tuesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. Revvity has a one year low of $81.36 and a one year high of $129.50. The stock has a market capitalization of $9.76 billion, a PE ratio of 35.62, a price-to-earnings-growth ratio of 2.23 and a beta of 0.94. The business's fifty day moving average is $91.23 and its 200 day moving average is $95.76.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The company had revenue of $720.28 million for the quarter, compared to analysts' expectations of $711.26 million. During the same period last year, the firm posted $1.22 earnings per share. Revvity's revenue was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS.

Institutional Trading of Revvity

Large investors have recently added to or reduced their stakes in the company. CYBER HORNET ETFs LLC bought a new stake in Revvity in the 2nd quarter worth approximately $32,000. MUFG Securities EMEA plc bought a new stake in Revvity in the 2nd quarter worth approximately $34,000. UMB Bank n.a. increased its stake in Revvity by 138.8% in the 2nd quarter. UMB Bank n.a. now owns 406 shares of the company's stock worth $39,000 after acquiring an additional 236 shares during the last quarter. CVA Family Office LLC increased its stake in Revvity by 79.0% in the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company's stock worth $40,000 after acquiring an additional 181 shares during the last quarter. Finally, Vermillion Wealth Management Inc. bought a new stake in Revvity in the 4th quarter worth approximately $41,000. Institutional investors own 86.65% of the company's stock.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Friday, October 17th. Revvity's dividend payout ratio (DPR) is 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.